Active Pharma Inc.
Active Pharma Inc., headquartered in California, is a prominent player in the pharmaceutical industry, specialising in the development and distribution of innovative healthcare solutions. Founded in [year], the company has established a strong presence across major operational regions, focusing on both prescription and over-the-counter products. With a commitment to quality and efficacy, Active Pharma Inc. offers a diverse range of core products, including advanced formulations and generics that cater to various therapeutic areas. Their unique approach to research and development has positioned them as a trusted name in the market, achieving notable milestones in product launches and regulatory approvals. Recognised for their dedication to improving patient outcomes, Active Pharma Inc. continues to enhance its market position through strategic partnerships and a robust pipeline of future innovations.
DitchCarbon Score
How does Active Pharma Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Active Pharma Inc.'s score of 3 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Active Pharma Inc.'s reported carbon emissions
In 2023, Active Pharma Inc. reported significant carbon emissions, with Scope 1 emissions totalling approximately 11,168,000 kg CO2e and Scope 2 emissions reaching about 43,425,000 kg CO2e. This results in a combined total of approximately 54,593,000 kg CO2e for these two scopes. The company also disclosed an emission intensity of about 8,890 kg CO2e per tonne of physical output for Scope 1 and Scope 2. For the following year, 2024, emissions increased, with Scope 1 emissions reported at approximately 33,489,000 kg CO2e and Scope 2 emissions at about 43,622,000 kg CO2e, leading to a total of approximately 77,111,000 kg CO2e. The emission intensity for this period was noted to be around 10,890 kg CO2e per tonne of physical output. Despite these figures, Active Pharma Inc. has not established specific reduction targets or climate pledges, indicating a potential area for improvement in their climate commitments. The absence of defined reduction initiatives suggests that the company may need to enhance its strategies to address its carbon footprint effectively.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2023 | 2024 | |
|---|---|---|
| Scope 1 | 11,168,000 | 00,000,000 |
| Scope 2 | 43,425,000 | 00,000,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Active Pharma Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
